Mucocutaneous Lymph Node Syndrome Clinical Trial
Official title:
Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017
To investigate the epidemiologic features of Kawasaki disease (KD) in Shanghai from 2013 through 2017 and identify the risk factors for coronary artery lesions.
Based on the KD research group network established during the first survey in Shanghai, a set of questionnaires and diagnostic guidelines for KD will be sent to 50 hospitals providing pediatric medical care in Shanghai, China. Medical records of participants with KD diagnosed from January 2013 through December 2017 will be retrospectively analyzed. Data are collected by pediatricians, including demographic information, clinical manifestations, prognosis, laboratory indexes, treatment and echocardiographic findings. Age and seasonal distribution at onset, treatment and cardiac abnormalities wil be described. Univariate and multivariate analyses will be performed to identify risk factors for coronary artery lesions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00841789 -
A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease
|
Phase 2 | |
| Completed |
NCT00000520 -
Prevention of Coronary Aneurysms in Kawasaki Syndrome
|
Phase 2 | |
| Completed |
NCT03065244 -
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
|
Phase 3 | |
| Recruiting |
NCT04509219 -
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
|
Phase 1 |